| pubmed-article:21343561 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C1515948 | lld:lifeskim |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C1706244 | lld:lifeskim |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C0282451 | lld:lifeskim |
| pubmed-article:21343561 | lifeskim:mentions | umls-concept:C1519814 | lld:lifeskim |
| pubmed-article:21343561 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:21343561 | pubmed:dateCreated | 2011-3-18 | lld:pubmed |
| pubmed-article:21343561 | pubmed:abstractText | To update the recommendations on the role of bone-modifying agents in the prevention and treatment of skeletal-related events (SREs) for patients with metastatic breast cancer with bone metastases. | lld:pubmed |
| pubmed-article:21343561 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21343561 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21343561 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21343561 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:21343561 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:American... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:BiermannJ... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:TheriaultRich... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:BarlowWilliam... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:Von... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:JanjanNora... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:HillnerBruce... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:YeeGary CGC | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:BossermanLind... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:TeminSarahS | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:GeogheganCind... | lld:pubmed |
| pubmed-article:21343561 | pubmed:author | pubmed-author:ZuckermanDan... | lld:pubmed |
| pubmed-article:21343561 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21343561 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:21343561 | pubmed:volume | 29 | lld:pubmed |
| pubmed-article:21343561 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21343561 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21343561 | pubmed:pagination | 1221-7 | lld:pubmed |
| pubmed-article:21343561 | pubmed:dateRevised | 2011-10-18 | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:meshHeading | pubmed-meshheading:21343561... | lld:pubmed |
| pubmed-article:21343561 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21343561 | pubmed:articleTitle | American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. | lld:pubmed |
| pubmed-article:21343561 | pubmed:affiliation | University of Michigan, Ann Arbor, MI, USA. | lld:pubmed |
| pubmed-article:21343561 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21343561 | pubmed:publicationType | Practice Guideline | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21343561 | lld:pubmed |
